Correction: Identifying the Optimal Anticancer Targets from the Landscape of a Cancer-Immunity Interaction Network.

Chunhe Li

DOI: https://doi.org/10.1039/c7cp90084h

2017-01-01

Abstract:Correction for 'Identifying the optimal anticancer targets from the landscape of a cancer-immunity interaction network' by Chunhe Li et al., Phys. Chem. Chem. Phys., 2017, 19, 7642-7651.

What problem does this paper attempt to address?

Identifying the Optimal Anticancer Targets from the Landscape of a Cancer–immunity Interaction Network

Chunhe Li

DOI: https://doi.org/10.1039/c6cp07767f

IF: 3.3

2017-01-01

Physical Chemistry Chemical Physics

Abstract:The landscape and optimization of transition actions provide a new physical and quantitative way to understand the mechanisms of cancer immunotherapy and identify the optimal combinations of targets for the cancer–immunity interplay.
Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Jing Zheng,Tao Xu,Feng Chen,Ying Zhang

DOI: https://doi.org/10.1007/s12253-020-00794-3

2020-01-01

Abstract:The original version of this article unfortunately contained an error in the affiliation section.
Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Tao Wang,Tianye Li,Baiqing Li,Jiahui Zhao,Zhi Li,Mingyi Sun,Yan Li,Yanjiao Zhao,Shidi Zhao,Weiguang He,Xiao Guo,Rongjing Ge,Lian Wang,Dushan Ding,Saisai Liu,Simin Min,Xiaonan Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1134847

IF: 7.3

2023-01-20

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.805184.].

immunology
Correction: De Sanctis et al. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event. Cancers 2024, 16, 2630

Juan Bautista De Sanctis,Jenny Valentina Garmendia,Hana Duchová,Viktor Valentini,Alex Puskasu,Agáta Kubíčková,Marián Hajdúch

DOI: https://doi.org/10.3390/cancers16234117

2024-12-10

Cancers

Abstract:Cancers, Vol. 16, Pages 4117: Correction: De Sanctis et al. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event. Cancers 2024, 16, 2630 Cancers doi: 10.3390/cancers16234117 Authors: Juan Bautista De Sanctis Jenny Valentina Garmendia Hana Duchová Viktor Valentini Alex Puskasu Agáta Kubíčková Marián Hajdúch In the original publication [...]

oncology
Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Cunqing Kong,Xingcai Chen

DOI: https://doi.org/10.2147/ijn.s422584

IF: 7.033

2023-05-01

International Journal of Nanomedicine

Abstract:[This corrects the article DOI: 10.2147/IJN.S388996.].

pharmacology & pharmacy,nanoscience & nanotechnology
Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Zekun Li,Yongchun Pan,Shizheng Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qiang Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

Davide Bedognetti,Michele Ceccarelli,Lorenzo Galluzzi,Rongze Lu,Karolina Palucka,Josue Samayoa,Stefani Spranger,Sarah Warren,Kwok-Kin Wong,Elad Ziv,Diego Chowell,Lisa M Coussens,Daniel D De Carvalho,David G DeNardo,Jérôme Galon,Howard L Kaufman,Tomas Kirchhoff,Michael T Lotze,Jason J Luke,Andy J Minn,Katerina Politi,Leonard D Shultz,Richard Simon,Vésteinn Thórsson,Joanne B Weidhaas,Maria Libera Ascierto,Paolo Antonio Ascierto,James M Barnes,Valentin Barsan,Praveen K Bommareddy,Adrian Bot,Sarah E Church,Gennaro Ciliberto,Andrea De Maria,Dobrin Draganov,Winson S Ho,Heather M McGee,Anne Monette,Joseph F Murphy,Paola Nisticò,Wungki Park,Maulik Patel,Michael Quigley,Laszlo Radvanyi,Harry Raftopoulos,Nils-Petter Rudqvist,Alexandra Snyder,Randy F Sweis,Sara Valpione,Roberta Zappasodi,Lisa H Butterfield,Mary L Disis,Bernard A Fox,Alessandra Cesano,Francesco M Marincola,Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups

DOI: https://doi.org/10.1186/s40425-019-0640-y

2019-07-04

Abstract:Following publication of the original article [1], the author reported that an author name, Roberta Zappasodi, was missed in the authorship list.
Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Zekun Li,Yongchun Pan,Shiyu Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qin Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Chunbo Li,Keqin Hua

DOI: https://doi.org/10.3389/fimmu.2024.1386072

IF: 7.3

2024-02-23

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.897366.].

immunology
Correction: Corrigendum: Identification of High-Quality Cancer Prognostic Markers and Metastasis Network Modules

Jie Li,Anne E.G. Lenferink,Yinghai Deng,Catherine Collins,Qinghua Cui,Enrico O. Purisima,Maureen D. O’Connor-McCourt,Edwin Wang

DOI: https://doi.org/10.1038/ncomms1400

IF: 16.6

2012-01-01

Nature Communications

Abstract:Nature Communications 1: Article number: 34 (2010); Published: 13 July 2010; Updated: 31 January 2012. In the Supplementary Software associated with this Article, there is an error in the R code file, gettop30genes.R. Line 51 of the file should read: top30geneid<-geneidrank[1:30,1]
Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”

Bi-Cheng Wang,Bo-Ya Xiao,Peng-Cheng Li,Bo-Hua Kuang,Wang-Bing Chen,Pin-Dong Li,Guo-He Lin,Quentin Liu

DOI: https://doi.org/10.1155/2021/3735726

IF: 4.501

2021-02-25

Journal of Oncology

Abstract:[This corrects the article DOI: 10.1155/2020/2368164.].

oncology
Correction: Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy

Tingting Wang,Jingchao Li,Xun Zhang,Chengao Li,Jiang Ming,Jian Li,Dongsheng Zhang,Jun Yang,Nian Liu,Xinhui Su

DOI: https://doi.org/10.1039/d4cc90284j

2024-08-29

Abstract:Correction for 'Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy' by Tingting Wang et al., Chem. Commun., 2024, https://doi.org/10.1039/d4cc03281k.
Corrigendum: Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell Transcriptomes

Jia Yao,Shengwei Li,Xiaosheng Wang

DOI: https://doi.org/10.3389/fcell.2022.948644

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.781848.].
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology
Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Yuanyuan Chen,Hui Zhong,Jianbo Wang,Xiuyan Wan,Yanhua Li,Wei Pan,Na Li,Bo Tang

DOI: https://doi.org/10.1039/d0sc90108c

IF: 8.4

2020-01-01

Chemical Science

Abstract:Correction for ‘Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence’ by Yuanyuan Chen et al., Chem. Sci., 2019, 10, 5773–5778, DOI: 10.1039/C9SC00747D.
Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Huaxia Shi,Wucheng Sun,Changbing Liu,Guiying Gu,Bo Ma,Weili Si,Nina Fu,Qi Zhang,Wei Huang,Xiaochen Dong

DOI: https://doi.org/10.1039/d3tb90090h

IF: 7.571

2023-01-01

Journal of Materials Chemistry B

Abstract:Correction for ‘Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy’ by Huaxia Shi et al. , J. Mater. Chem. B , 2016, 4 , 113–120, https://doi.org/10.1039/C5TB02041G.

materials science, biomaterials
Corrigendum to “remodeling Tumor Immunosuppressive Microenvironment Via a Novel Bioactive Nanovaccines Potentiates the Efficacy of Cancer Immunotherapy” [bioactive Mater. 16 107–119]

Xiaoxue Xie,Yi Feng,Hanxi Zhang,Qingqing Su,Ting Song,Geng Yang,Ningxi Li,Xiaodan Wei,Tingting Li,Xiang Qin,Shun Li,Chunhui Wu,Xiaojuan Zhang,Guixue Wang,Yiyao Liu,Hong Yang

DOI: https://doi.org/10.1016/j.bioactmat.2022.09.001

IF: 18.9

2023-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.03.008.].
Correction To: Predictive Biomarkers and Mechanisms Underlying Resistance to PD1/PD-L1 Blockade Cancer Immunotherapy.

Daixi Ren,Yuze Hua,Boyao Yu,Xin Ye,Ziheng He,Chunwei Li,Jie Wang,Yongzhen Mo,Xiaoxu Wei,Yunhua Chen,Yujuan Zhou,Qianjin Liao,Hui Wang,Bo Xiang,Ming Zhou,Xiaoling Li,Guiyuan Li,Yong Li,Zhaoyang Zeng,Wei Xiong

DOI: https://doi.org/10.1186/s12943-020-01148-y

IF: 37.3

2020-01-01

Molecular Cancer

Abstract:After publication of the article [1], authors found out that Fig. 1 was inadvertently replaced.

Correction: Identifying the Optimal Anticancer Targets from the Landscape of a Cancer-Immunity Interaction Network.

Identifying the Optimal Anticancer Targets from the Landscape of a Cancer–immunity Interaction Network

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Correction: De Sanctis et al. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event. Cancers 2024, 16, 2630

Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Correction: Corrigendum: Identification of High-Quality Cancer Prognostic Markers and Metastasis Network Modules

Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”

Correction: Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy

Corrigendum: Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell Transcriptomes

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Corrigendum to “remodeling Tumor Immunosuppressive Microenvironment Via a Novel Bioactive Nanovaccines Potentiates the Efficacy of Cancer Immunotherapy” [bioactive Mater. 16 107–119]

Correction To: Predictive Biomarkers and Mechanisms Underlying Resistance to PD1/PD-L1 Blockade Cancer Immunotherapy.